المؤلفون: Pierpaolo Pellicori, Blerim Mujaj, Stephane Heymans, Fozia Z Ahmed, N. Girerd, Ping Wang, Arantxa González, Hans-Peter Brunner-La-Rocca, Javier Díez, Franco Cosmi, Frank T. Edelmann, Mark R. Hazebroek, João Pedro Ferreira, Joe Cuthbert, Andrew L. Clark, Johannes Petutschnigg, Mamas A. Mamas, Roberto Latini, Job A J Verdonschot, John G.F. Cleland, Beatrice Mariottoni, Patrick Rossignol, Javed Khan, Jan A. Staessen, Burkert Pieske, Faiez Zannad, Anne Pizard, Stéphanie Grojean, Timothy Collier, Philippe Rouet

المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], London School of Hygiene and Tropical Medicine (LSHTM), University of Manchester [Manchester], University of Hull [United Kingdom], Cortona Hospital, Universidad de Navarra [Pamplona] (UNAV), German Heart Institute Berlin, University of Glasgow, Mario Negri Institute, Center for Human Genetics, University of Leuven School of Medicine, SCHOOL of MEDICINE [Louvain], Université Catholique de Louvain = Catholic University of Louvain (UCL)-Université Catholique de Louvain = Catholic University of Louvain (UCL), Centre d'anthropologie et de génomique de Toulouse (CAGT), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Author Disclosures HOMAGE was funded by a grant from the European Union 7th Framework Programme for Research and Technological Development (HEALTH-F7-305507 HOMAGE (EU FP7 305507 http://www.homage-hf.euTest). Drs. Ferreira, Rossignol, Girerd, and Zannad are supported by the RHU Fight-HF, a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d’Avenir' program (reference: ANR-15-RHUS-0004), the French PIA project 'Lorraine Université d’Excellence' (reference: ANR-15-IDEX-04-LUE), Contrat de Plan Etat Lorraine IT2MP, and FEDER Lorraine. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015), European Project: 305507,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HOMAGE(2013), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), DE CARVALHO, Philippe, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, Heart OMics in AGEing - HOMAGE - - EC:FP7:HEALTH2013-02-01 - 2019-01-31 - 305507 - VALID, RS: Carim - H02 Cardiomyopathy, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), MUMC+: MA Med Staf Artsass Cardiologie (9)

المصدر: JACC: Heart Failure
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD

مصطلحات موضوعية: Male, Proteomics, [SDV]Life Sciences [q-bio], Adipokine, Inflammation, 030204 cardiovascular system & hematology, Pharmacology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Mineralocorticoid receptor, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Fibrosis, Renin–angiotensin system, Natriuretic Peptide, Brain, medicine, Humans, 030212 general & internal medicine, Aged, Mineralocorticoid Receptor Antagonists, Heart Failure, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, business.industry, fibrosis, spironolactone, HEART-FAILURE INSIGHTS, medicine.disease, Brain natriuretic peptide, 3. Good health, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, CARDIAC MATRIX BIOMARKERS, [SDV] Life Sciences [q-bio], renin-angiotensin-aldosterone system, chemistry, MYOCARDIAL-INFARCTION, inflammation, Heart failure, Spironolactone, SURVIVAL, EPLERENONE, Female, medicine.symptom, Cardiology and Cardiovascular Medicine, business, heart failure prevention, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff2f9ef636912f7d1efd60c7c971fbe4Test
https://cris.maastrichtuniversity.nl/en/publications/f2280d92-dac9-4b92-a4fa-39b9afb82d38Test

المؤلفون: Andrew L. Clark, Javier Díez, Pierpaolo Pellicori, Investigators, Nicolas Girerd, Job A J Verdonschot, João Pedro Ferreira, Susana Ravassa, Frank Edelmann, Stephane Heymans, Beatrice Mariottoni, María U. Moreno, Homage Trial Committees, Franco Cosmi, Jan A. Staessen, Burkert Pieske, John G.F. Cleland, Faiez Zannad, Johannes Petutschnigg, Mark R. Hazebroek, Joe Cuthbert, Arantxa González, Begoña López, Erwan Bozec

المساهمون: Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain, CIBERCV, Carlos III Institute of Health, Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow Royal Infirmary, Department of Cardiology, Cortona Hospital, Department of Cardiology, Maastricht University Medical Center, Cardiology Department, Castle Hill Hospital, University of Hull, Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, and German Centre for Cardiovascular research (DZHK), Partner Site Berlin, Non-Profit Research Institute Alliance for the Promotion of Preventive Medicine, Mechelen (APPREMED), Biomedical Sciences Group, Faculty of Medicine, University of Leuven, Berlin Institute of Health (BIH), Departments of Nephrology and Cardiology, Clínica Universidad de Navarra, This work was supported by the European Commission HOMAGE project (grant 305507), JD and AG are supported by the Ministry of Science and Innovation, Spain (Instituto de Salud Carlos III: CB16/11/00483 and PI18/01469 co-financed by FEDER funds). MH is supported by a Kootstra Talented Post-doc Fellowship (Netherlands). JGFC and PP are supported by the British Heart Foundation Centre of Research Excellence (grant number RE/18/6/34217). PPREMED (URL: http://www.appremed.orfTest) received a non-binding grant from Omron Healthcare Co., Ltd., Kyoto, Japan., European Project: 305507, BOZEC, Erwan, HOMAGE (Heart Omics in Ageing consortium) - 305507 - INCOMING, MUMC+: MA Med Staf Artsass Cardiologie (9), RS: Carim - H02 Cardiomyopathy, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9)

المصدر: European Journal of Heart Failure
European Journal of Heart Failure, European Society of Cardiology (Wiley), 2021, ⟨10.1002/ejhf.2394⟩
Dadun. Depósito Académico Digital de la Universidad de Navarra
Consejo Superior de Investigaciones Científicas (CSIC)
European Journal of Heart Failure, Oxford University Press (OUP), 2021, ⟨10.1002/ejhf.2394⟩
European journal of heart failure, 24(2), 321-331. Wiley

مصطلحات موضوعية: Cardiac function curve, medicine.medical_specialty, Cardiac & Cardiovascular Systems, Heart failure, 030204 cardiovascular system & hematology, Spironolactone, EXERCISE CAPACITY, Atrial remodelling, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, N-terminal telopeptide, Left atrial, Collagen cross-linking, Internal medicine, MAGNETIC-RESONANCE, medicine, FIBROSIS, 030212 general & internal medicine, Science & Technology, Ejection fraction, business.industry, medicine.disease, DYSFUNCTION, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, PRESERVED EJECTION FRACTION, chemistry, VOLUME, Cardiovascular System & Cardiology, SURVIVAL, Cardiology, Biomarker (medicine), FIBRILLATION, Cardiology and Cardiovascular Medicine, business, Life Sciences & Biomedicine, Blood sampling

وصف الملف: application/pdf; Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23cf6004dd43e1e3a891d35bf846cb9cTest
https://hdl.handle.net/10171/63765Test

المؤلفون: Lutgarde Thijs, Beatrice Mariottoni, Johannes Petutschnigg, Andrew L. Clark, Mamas A. Mamas, Patrick Rossignol, Frank Edelmann, Pierpaolo Pellicori, Timothy Collier, Franco Cosmi, Fozia Z Ahmed, Arantxa González, João Pedro Ferreira, Blerim Mujaj, Mark R. Hazebroek, Joe Cuthbert, Philippe Rouet, Stephane Heymans, Hans-Peter Brunner-La Rocca, Nicolas Girerd, Job A J Verdonschot, Jan A. Staessen, John G.F. Cleland, Faiez Zannad

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), London School of Hygiene and Tropical Medicine (LSHTM), University of Hull [United Kingdom], Castle Hill Hospital, University of Manchester [Manchester], Manchester Academic Health Science Centre (MAHSC), Keele University [Keele], Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], Center for Applied Medical Research [Plamplona] (CIMA), Universidad de Navarra [Pamplona] (UNAV), Clínica Universidad de Navarra [Pamplona], CIBERCV, Carlos III Institute of Health, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Charité Campus Virchow-Klinikum (CVK), Universitäts Klinikum Freiburg = University Medical Center Freiburg (Uniklinik), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), University of Glasgow, Cortona Hospital, Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), HOMAGE was funded by a grant from the European Union 7th Framework Programme for Research and Technological Development (HEALTH-F7-305507 HOMAGE (EU FP7 305507 http://www.homage-hf.euTest). JPF, PR, NG, FZ are supported by the RHU Fight-HF, a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d’Avenir' program (reference: ANR-15-RHUS-0004), by the French PIA project 'Lorraine Université d’Excellence' (reference: ANR-15-IDEX-04-LUE), Contrat de Plan Etat Lorraine IT2MP and FEDER Lorraine., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015), European Project: 305507,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HOMAGE(2013), European Project, Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Freiburg University Medical Center, Hôpital de Rangueil, CHU Toulouse [Toulouse], Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H02 Cardiomyopathy, MUMC+: MA Med Staf Artsass Cardiologie (9), BOZEC, Erwan, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, Heart OMics in AGEing - HOMAGE - - EC:FP7:HEALTH2013-02-01 - 2019-01-31 - 305507 - VALID, Entreprises lorraines, parties prenantes et Développement Durable (FEDER) (Région Lorraine) - INCOMING

المصدر: European Heart Journal-Cardiovascular Pharmacotherapy
European Heart Journal-Cardiovascular Pharmacotherapy, 2021, ⟨10.1093/ehjcvp/pvab031⟩
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2021, ⟨10.1093/ehjcvp/pvab031⟩
European Heart Journal-Cardiovascular Pharmacotherapy, 8(2), 149-156. Oxford University Press

مصطلحات موضوعية: cardiovascular risk, Male, medicine.medical_specialty, ALDOSTERONISM, hypertension, IMPACT, Developing heart, Blood Pressure, 030204 cardiovascular system & hematology, Spironolactone, Sitting, Coronary artery disease, RESISTANT HYPERTENSION, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Diabetes mellitus, Renin–angiotensin system, medicine, MANAGEMENT, FIBROSIS, Humans, Pharmacology (medical), 030212 general & internal medicine, Prospective Studies, Aged, Mineralocorticoid Receptor Antagonists, Heart Failure, business.industry, R735, medicine.disease, Omics, RC666, R1, PREVENTION, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Blood pressure, spironolactone, chemistry, renin, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, TASK-FORCE

وصف الملف: application/pdf; Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51291ffb39695fa7fd47e8e135cb3fa6Test
https://pubmed.ncbi.nlm.nih.gov/33822033Test

المؤلفون: João Pedro Ferreira, Patrick Rossignol, Faiez Zannad

المصدر: European Journal of Heart Failure. 20:1300-1302

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Stroke volume, 030204 cardiovascular system & hematology, medicine.disease, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, Fibrosis, Heart failure, Internal medicine, medicine, Spironolactone, Biomarker (medicine), Myocardial fibrosis, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::254d45de0a6d255a4a4103e8f90a423cTest
https://doi.org/10.1002/ejhf.1214Test

المؤلفون: Jean-Loup Machu, João Pedro Ferreira, Anne-Cecile Huby, Timothy Collier, Naveed Sattar, Javier Díez, Peter S. Sever, Nicolas Girerd, John G.F. Cleland, Faiez Zannad, Anne Pizard, Arantxa González, Patrick Rossignol, Begoña López

المساهمون: Foundation for Circulatory Health, National Institute for Health Research

المصدر: Heart (British Cardiac Society). 105(4)

مصطلحات موضوعية: Male, Cardiac & Cardiovascular Systems, CROSS-LINKING, Drug Resistance, Blood Pressure, 030204 cardiovascular system & hematology, Spironolactone, chemistry.chemical_compound, DOUBLE-BLIND, 0302 clinical medicine, Mineralocorticoid receptor, Fibrosis, Outcome Assessment, Health Care, FIBROSIS, 030212 general & internal medicine, 1102 Cardiorespiratory Medicine and Haematology, Mineralocorticoid Receptor Antagonists, HEART-FAILURE INSIGHTS, Dilated cardiomyopathy, Middle Aged, Eplerenone, Hypertension, TRIAL, Female, Collagen, Drug Monitoring, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, Procollagen, medicine.drug, medicine.medical_specialty, EXTRACELLULAR-MATRIX TURNOVER, Urology, Biological Availability, 03 medical and health sciences, medicine, Humans, In patient, Aged, Heart Failure, Science & Technology, business.industry, ELEVATION MYOCARDIAL-INFARCTION, medicine.disease, DILATED CARDIOMYOPATHY, R1, DYSFUNCTION, Peptide Fragments, Blood pressure, chemistry, Cardiovascular System & Hematology, Heart failure, Cardiovascular System & Cardiology, EPLERENONE, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0fa03509cfe3dd383ac08c415d3edf5Test
https://pubmed.ncbi.nlm.nih.gov/30121630Test